Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
07/2002
07/11/2002CA2433176A1 Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene
07/11/2002CA2432339A1 Identification of the genetic determinants of the polymorphic cyp3a5 expression
07/11/2002CA2431887A1 Control of sex determination in mammals
07/11/2002CA2430667A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
07/10/2002EP1221283A2 Transgenic animal for screening therapeutic agents for brain tumors
07/10/2002EP1220929A1 Human ubiquitin protease
07/10/2002EP1220928A2 Compositions and methods for altering gene expression
07/10/2002EP1220918A2 Hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use
07/10/2002EP1220914A1 Human g-protein coupled receptor
07/10/2002EP1220913A1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof
07/10/2002EP1220906A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby
07/10/2002EP1220889A1 Astrocyte apparatus for bioprocessing a circulating fluid
07/10/2002EP1220864A1 Transgenically produced fusion proteins
07/10/2002EP1220606A1 Methods of producing a target molecule in a transgenic animal and purification of the target molecule
07/10/2002CN2498836Y Autoamtic temperature control and humidity control scorpion cultivation house
07/10/2002CN1357514A Method for making organic fertilizer by utilizing housefly larva to ecologically treat pig dung
07/10/2002CN1087139C Breeding and raising method of meat qinglong dog
07/09/2002US6417328 Isolated genes encoding tumor necrosis factor-related apotosis-inducing ligand (trail) receptor splice variant cdna sequences, or active fragment; immunogens, modulation therapeutic autoimmune diseases, aids
07/09/2002US6416998 Polypeptides
07/05/2002CA2367001A1 The method for production of egg containing anti-e.coli igy and anti-helicobacter pylori igy and anti-salmonella enteritidis igy and anti-salmonella typhimurium igy simultaneously, and egg, yolk, yogurt and ice cream containing specific igy for anti-e.coli, anti-helicobacter pylori, anti-salmonella enteritidis and anti-salmonella typhimurium
07/04/2002WO2002052244A2 Separation of x- and y-sperm cells
07/04/2002WO2002052023A2 Position-independent and tissue specific expression of a transgene in milk of transgenic animals
07/04/2002WO2002052018A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
07/04/2002WO2002052009A1 Human fgf23 protein mutant lowering blood phosphorus level
07/04/2002WO2002052007A1 Synovial membrane cell protein
07/04/2002WO2002052004A1 Gene involved in apoptosis regulation
07/04/2002WO2002052001A1 Method of identifying dna encoding physiologically active polypeptide in mammalian body
07/04/2002WO2002051997A1 Methods for cloning mammals using reprogrammed donor chromatin or donor cells
07/04/2002WO2002051988A2 Thymic epithelial progenitor cells and uses thereof
07/04/2002WO2002051987A1 System for the cell-specific and development-specific selection of differentiating embryonic stem cells, adult stem cells and embryonic germline cells
07/04/2002WO2002051355A2 Acetyl-coenzyme a carboxylase 2 as a target in fat regulation and insulin action
07/04/2002WO2002014473A8 Animals expressing exogenous igf-i in their milk
07/04/2002WO2002002624A3 B7-like molecules and uses thereof
07/04/2002WO2001092492A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
07/04/2002WO2001088109A3 Model for neurodegenerative disease
07/04/2002WO2001083563A3 Method of identifying agents that alter the activity of the promoter sequence for crf receptor 2-alpha
07/04/2002US20020088019 Methods of and pharmaceutical compositions for improving implantation of embryos
07/04/2002US20020088018 Transgenic mice containing MAS orphan receptor gene disruptions
07/04/2002US20020088017 Genetically engineered rodents; for use as anima,l models for evaluating respiratory, nervous system, cardiovascular, vascular, kidney, bone, reproductive and immunological disorders
07/04/2002US20020088014 Minimal adenovirus mediated recombinant vaccine
07/04/2002US20020086845 Rat PTTG polypeptide and method for producing it
07/04/2002US20020086444 Isolated menbrane protein for use in the diagnosis and treatment of alzheimer's disease
07/04/2002US20020086426 Controlling gene expression; obtain cell, transform with expression vector, transcribe and monitor generation of tetracycline
07/04/2002US20020086381 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
07/04/2002US20020086305 Human c-Maf compositions and methods of use thereof
07/04/2002US20020086297 Gene alteration in the gene for the Gbeta3-subunit of the human G protein
07/04/2002US20020086014 Human sequence antibody that specifically binds to human CTLA-4; nucleic acid encoding a heavy chain of a human sequence antibody; polyvalent complex; transgenic non-human; treating an autoimmune disease
07/04/2002CA2433171A1 Human fgf23 protein mutants decreasing blood phosphorus level
07/04/2002CA2432943A1 Position-independent and tissue specific expression of a transgene in milk of transgenic animals
07/04/2002CA2432415A1 Acetyl-coenzyme a carboxylase 2 as a target in fat regulation and insulin action
07/04/2002CA2432214A1 Gene involved in apoptosis regulation
07/04/2002CA2432168A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
07/04/2002CA2431478A1 Synovial cell protein
07/04/2002CA2429481A1 Separation of x- and y-sperm cells
07/03/2002EP1219638A2 G-protein coupled receptors having homology to the P2Y purinoreceptor 1 (P2Y1)
07/03/2002EP1218751A2 Diagnosis of coeliac disease using a gliadin epitope
07/03/2002EP1218509A2 Fibroblast growth factor-like polypeptides
07/03/2002EP1218412A2 Human g-protein coupled receptor
07/03/2002EP1181351A4 Method of purifying heterologous proteins
07/03/2002EP0437576B1 Homologous recombination for universal donor cells and chimeric mammalian hosts
07/03/2002CN2498113Y Silkworm oviposit box
07/02/2002US6414220 Galanin transgenic mice
07/02/2002US6414218 Mouse model for rheumatoid arthritis
07/02/2002US6414129 Cells containing expression vectors; diagnosis; immunomodulator detection; genetic engineering
07/02/2002US6414117 Compositions and methods for the treatment and diagnosis of immune disorders
07/02/2002US6413769 α(1,3) galactosyltransferase negative porcine cells
07/02/2002US6413762 Viral nucleotide sequences
07/02/2002US6413756 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
07/02/2002US6413755 Human checkpoint kinase, HCDS1, compositions and methods
07/02/2002US6413719 KCNQ2 and KCNQ3-potassium channel genes which are mutated in benign familial neonatal convulsions (BFNC) and other epilepsies
07/02/2002US6413511 Cartilage alterations by administering to joints chondrocytes comprising a heterologous polynucleotide
06/2002
06/27/2002WO2002050286A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
06/27/2002WO2002050283A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
06/27/2002WO2002050255A2 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof
06/27/2002WO2002050096A1 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
06/27/2002WO2002049423A1 Joint utilization of the insulin gene and the glucokinase gene in the development of therapeutic approaches for diabetes mellitus
06/27/2002WO2002049422A2 Non-human animal disease models
06/27/2002WO2002016548A3 Novel g protein-coupled receptor
06/27/2002WO2002012543A3 Two coloured fluorimetric protease assay
06/27/2002WO2001098536A3 METHOD FOR ACTIVATING PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-$g(g)
06/27/2002WO2001083746A3 Regulatory nucleic acid sequences of the abc1 gene
06/27/2002WO2001070978A3 Polypeptides and nucleic acids encoding same
06/27/2002WO2001051672A3 System and method for controlling male fertility
06/27/2002US20020083482 Method for breeding disease resistant domesticated fowl
06/27/2002US20020083481 Vectors and methods for the mutagenesis of mammalian genes
06/27/2002US20020083479 Insertion of nucleotide sequences into genome of germ cells; obtain gonads, incubate with transfection mixture, allow insertion, monitor cells for preferential marker
06/27/2002US20020083478 Immune defective rodents; for use ae animal model in the treatment of human prostate cancer
06/27/2002US20020082412 Methods
06/27/2002US20020082388 Polypeptide for use in the treatment, diagnosis and prevention of cancer, nervous system and developmental disorders
06/27/2002US20020082190 Amino acid sequences of the transport proteins encoded by genes within the human genome; isolated peptide and nucleic acid molecules, methods of identifying orthologs, paralogs and modulators of the kinase peptides; brain disorders
06/27/2002US20020081739 Genetically engineering cells; obtain cell, obtain nucleotide sequences, adhere sequences to sheets, propel sheet into cells, recover transformed cells
06/27/2002US20020081653 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/27/2002US20020081649 Peptide for use in human therapeutics and diagnostics; for use as a antitumor agent
06/27/2002US20020081648 Peptide for use in human thereapeutics and diagnostics
06/27/2002US20020081633 Methods for using 22045, a human cyclic nucleotide phosphodiesterase
06/27/2002US20020081593 Screening heredity of preferential shellfish; obtain shellfish, extract mitochondrial nucleotide sequences, sequence nucleotide sequence, compare to other shellfish
06/27/2002US20020081286 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
06/27/2002US20020081282 Genetically engineered cell comprising DNA encoding a transmembrane LAG-3 protein (lymphocyte activting gene) on its surface resulting in the protection from graft rejection by a host's immune system
06/27/2002CA2714357A1 Mutations in neuronal gene sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
06/27/2002CA2432762A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof